Positron-emission tomography in epilepsy

Magnetic Resonance in Epilepsy

Volumn , Issue , 2005, Pages 395-411

  Juhász, Csaba ^a   Chugani, Diane C ^a   Muzik, Otto ^a   Chugani, Harry T ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882817263     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012431152-7/50019-7     Document Type: Chapter

References (124)

1. Hoffman EJ, Phelps ME Positron emission tomography: principles and quantitation. Positron emission tomography and autoradiography: principles and applications for the brain and heart 1986, 237-286. Raven Press, New York. M.E. Phelps, J.C. Mazziotta, H.R. Schelbert (Eds.).
2. Ter Pogossian MM Positron emission tomography. Principles of nuclear medicine 1995, 342-346. WB Saunders, London. H.N. Wagner, Z. Szabo, J.W. Buchanan (Eds.).
3. Carson RE Precision and accuracy considerations of physiological quantitation in PET. J Cereb Blood Flow Metab 1991, 11:A45-A50.
4. 18FDG positron emission tomography. Science 1986, 231:840-843.
5. Chugani HT, Phelps ME, Mazziotta JC Positron emission tomography study of human brain functional development. Ann Neurol 1987, 22:487-497.
6. Theodore WH Antiepileptic drugs and cerebral glucose metabolism. Epilepsia 1988, 29(Suppl 2):S48-S55.
7. Theodore WH, Bromfield E, Onorati L The effect of carbamazepine on cerebral glucose metabolism. Ann Neurol 1989, 25:516-520.
8. Leiderman DB, Balish M, Bromfield EB, Theodore WH Effect of valproate on human cerebral glucose metabolism. Epilepsia 1991, 32:417-422.
9. 3. Ann Neurol 1980, 8:348-360.
10. Engel J, Kuhl DE, Phelps ME Patterns of human local cerebral glucose metabolism during epileptic seizures. Science 1982, 218:64-66.
11. Engel J, Kuhl DE, Phelps ME, Mazziotta JC Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982, 12:510-517.
12. Swartz BE, Tomiyasu U, Delgado-Escueta AV, et al. Neuroimaging in temporal lobe epilepsy: test sensitivity and relationships to pathology and postoperative outcome. Epilepsia 1992, 33:624-634.
13. Gaillard WD, Bhatia S, Bookheimer SY, et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995, 45:123-126.
14. Knowlton RC, Laxer KD, Ende G, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 1997, 42:829-837.
15. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998, 121:2067-2081.
16. Theodore WH, Sato S, Kufta CV, et al. FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia 1997, 38:81-86.
17. Engel J, Henry TR, Risinger MW, et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990, 40:1670-1677.
18. Theodore WH, Sato S, Kufta C, et al. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol 1992, 32:789-794.
19. 18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol 2001, 58:933-939.
20. 18FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology 2002, 58:717-722.
21. Akimura T, Yeh HS, Mantil JC, et al. Cerebral metabolism of the remote area after epilepsy surgery. Neurol Med Chir (Tokyo) 1999, 39:16-25.
22. Spanaki MV, Kopylev L, DeCarli C, et al. Postoperative changes in cerebral metabolism in temporal lobe epilepsy. Arch Neurol 2000, 57:1447-1452.
23. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 1993, 43:1998-2006.
24. 11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology 1999, 53:2037-2045.
25. Van Bogaert P, Massager N, Tugendhaft P, et al. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage 2000, 12:129-138.
26. Chugani HT, Shewmon DA, Khanna S, et al. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 1993, 9:10-15.
27. Chugani HT, Rintahaka PJ, Shewmon DA Ictal patterns of cerebral glucose utilization in children with epilepsy. Epilepsia 1994, 35:813-822.
28. Bittar RG, Andermann F, Olivier A, et al. Interictal spikes increase cerebral glucose metabolism and blood flow: a PET study. Epilepsia 1999, 40:170-178.
29. Hong SB, Han HJ, Roh SY, et al. Hypometabolism and interictal spikes during positron emission tomography scanning in temporal lobe epilepsy. Eur Neurol 2002, 48:65-70.
30. Sperling MR, Alavi A, Reivich M, et al. False lateralization of temporal lobe epilepsy with FDG positron emission tomography. Epilepsia 1995, 36:722-727.
31. Swartz BE, Halgren E, Delgado-Escueta AV, et al. Neuroimaging in patients with seizures of probable frontal lobe origin. Epilepsia 1989, 30:547-558.
32. Da Silva EA, Chugani DC, Muzik O, Chugani HT Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 1997, 38:1198-1208.
33. Muzik O, Chugani DC, Shen C, et al. Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci. Comput Aided Surg 1998, 3:74-82.
34. 18F-FDG PET studies in patients with extratemporal and temporal epileps. J Nucl Med 1999, 40:737-746.
35. 18F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002, 43:1167-1174.
36. Chugani HT, Shewmon DA, Peacock WJ, et al. Surgical treatment of intractable neonatal-onset seizures: the role of positron emission tomography. Neurology 1988, 38:1178-1188.
37. Muzik O, da Silva E, Juhász C, et al. Intracranial EEG vs flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 2000, 54:171-179.
38. Juhász C, Chugani DC, Muzik O, et al. Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography?. Ann Neurol 2000, 48:88-96.
39. Juhász C, Chugani DC, Muzik O, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 2001, 56:1650-1658.
40. Chugani HT, Shields WD, Shewmon DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990, 27:406-413.
41. Chugani HT, Shewmon DA, Shields WD, et al. Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia 1993, 34:764-771.
42. 18F]fluoro-D-glucose positron emission tomography. Ann Neurol 1987, 21:4-13.
43. Theodore WH, Rose D, Patronas N, et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann Neurol 1987, 21:14-21.
44. Chugani HT, Mazziotta JC, Phelps ME Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989, 114:244-253.
45. Lee JS, Asano E, Muzik O, et al. Sturge-Weber syndrome: correlation between clinical course and FDG PET findings. Neurology 2001, 57:189-195.
46. Rintahaka PJ, Chugani HT, Messa C, Phelps ME Hemimegalencephaly: evaluation with positron emission tomography. Pediatr Neurol 1993, 9:21-28.
47. Lee JS, Juhász C, Kaddurah AK, Chugani HT Patterns of cerebral glucose metabolism in early and late stages of rasmussen's syndrome. J Child Neurol 2001, 16:798-805.
48. Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology 2000, 54:1811-1821.
49. Jokeit H, Seitz RJ, Markowitsch HJ, et al. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy. Brain 1997, 120:2283-2294.
50. Chugani HT, Da Silva E, Chugani DC Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 1996, 39:643-649.
51. Juhász C, Behen ME, Muzik O, et al. Bilateral medial prefrontal and temporal neocortical hypometabolism in children with epilepsy and aggression. Epilepsia 2001, 42:991-1001.
52. Bachevalier J, Malkova L, Mishkin M Effects of selective neonatal temporal lobe lesions on socioemotional behavior in infant rhesus monkeys (Macaca mulatta). Behav Neurosci 2001, 115:545-559.
53. Sivilotti L, Nistri A GABA receptor mechanisms in the central nervous system. Prog Neurobiol 1991, 36:35-92.
54. 123I]iomazenil SPECT and GABA MRS. Epilepsia 1999, 40:1433-1438.
55. A receptors measured with positron emission tomography. Ann Neurol 2001, 49:618-626.
56. A receptor complex in vitro. Neuropharmacology 1995, 34:1169-1175.
57. Blomquist G, Pauli S, Farde L, et al. Maps of receptor binding parameters in the human brain-a kinetic analysis of PET measurements. Eur J Nucl Med 1990, 16:257-265.
58. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991, 11:735-744.
59. 18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatr 1993, 56:615-621.
60. 3H]flumazenil autoradiography in hippocampal sclerosis. Ann Neurol 1998, 43:618-626.
61. Nagy F, Chugani DC, Juhász C, et al. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex. J Cereb Blood Flow Metab 1999, 19:939-947.
62. 11C]flumazenil PET: activity images versus parametric images for the detection of neocortical epileptic foci. J Nucl Med 1999, 40:1985-1991.
63. Pintor M, Mefford IN, Hutter I, et al. Levels of biogenic amines, their metabolites and tyrosine hydroxylase activity in the human epileptic temporal cortex. Synapse 1990, 5:152-156.
64. Trottier S, Evrard B, Vignal JP, et al. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res 1996, 25:79-106.
65. Diksic M, Nagahiro S, Sourkes TL, Yamamoto YL A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab 1990, 10:1-12.
66. Cohen Z, Tsuiki K, Takada A, et al. In vivo-synthesized radioactively labelled alpha-methyl serotonin as a selective tracer for visualization of brain serotonin neurons. Synapse 1995, 21:21-28.
67. Madras BK, Sourkes TL Metabolism of α-methyl-tryptophan. Biochem Pharmacol 1965, 14:1499-1506.
68. Diksic M, Nagahiro S, Chaly T, et al. Serotonin synthesis rate measured in living dog brain by positron emission tomography. J Neurochem 1991, 56:153-162.
69. Muzik O, Chugani DC, Chakraborty P, et al. Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab 1997, 17:659-669.
70. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA 1997, 94:5308-5313.
71. Chugani DC, Muzik O, Chakraborty P, et al. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-l-tryptophan. Synapse 1998, 28:33-43.
72. Saito K, Nowak TS, Suyama K, et al. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J Neurochem 1993, 61:2061-2070.
73. Chugani DC, Muzik O Alpha[C-11]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 2000, 20:2-9.
74. Parsey RV, Oquendo MA, Simpson NR, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT(1A) receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 2002, 954:173-182.
75. Toczek MT, Carson RE, Lang L, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003, 60:749-756.
76. Frost JJ, Mayberg HS, Fisher RS, et al. Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 23; 231-237.
77. Mayberg HS, Sadzot B, Meltzer CC, et al. 1991 Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol 1988, 30:3-11.
78. 18F]cyclofoxy. Epilepsy Res 1992, 13:129-139.
79. 1 receptors in complex partial seizures. Lancet 1993, 341:238.
80. 11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 1999, 40:30-37.
81. 11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997, 120:1865-1876.
82. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping 1995, 2:189-210.
83. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996, 119:1677-1687.
84. Bouilleret V, Dupont S, Spelle L, et al. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol 2002, 51:202-208.
85. 11C-flumazenil PET study. Ann Neurol 1996, 40:188-198.
86. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998, 51:485-492.
87. 11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001, 56:897-906.
88. Richardson MP, Friston KJ, Sisodiya SM, et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. Brain 1997, 120:1961-1973.
89. A receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study. Epilepsia 2001, 42:1327-1334.
90. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002, 125:2257-2271.
91. Chevassus-Au-Louis N, Congar P, Represa A, et al. Neuronal migration disorders: heterotopic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci USA 1998, 95:10263-10268.
92. Von Stockhausen HM, Thiel A, Herholz K, Pietrzyk U A convenient method for topographical localization of intrcranial electrodes with MRI and a conventional radiograph. Neuroimage 1997, 5:S514.
93. Muzik O, Chugani DC, Shen C, et al. Assessment of the performance of FDG and FMZ PET imaging against the gold standard of invasive EEG monitoring for the detection of extratemporal lobe epileptic foci in children. Physiological imaging of the brain with PET 2001, 381-387. Academic Press, San Diego, CA. A. Gjedde, S.B. Hansen, G.M. Knudsen, O.B. Paulson (Eds.).
94. Wellmer J, von Oertzen J, Schaller C, et al. Digital photography and 3D MRI-based multimodal imaging for individualized planning of resective neocortical epilepsy surgery. Epilepsia 2002, 43:1543-1550.
95. Asano E, Chugani DC, Muzik O, et al. Multimodality imaging for improved detection of epileptogenic lesions in children with tuberous sclerosis complex. Neurology 2000, 54:1976-1984.
96. 11C]-flumazenil PET. Eur J Neurol 2002, 9:137-142.
97. Savic I, Persson A, Roland P, et al. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988, 2:863-866.
98. Szelies B, Weber-Luxenburger G, Pawlik G, et al. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 1996, 3:109-118.
99. 11C]flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 1999, 40:566-574.
100. Ryvlin P, Bouvard S, Le Bars D, Mauguiere F Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology 1999, 53:1882-1885.
101. 11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology 2000, 54:2252-2260.
102. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000, 54:332-339.
103. 11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995, 36:1225-1232.
104. Juhász C, Chugani DC, Muzik O, et al. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 2000, 55:825-834.
105. Arnold S, Berthele A, Drzezga A, et al. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia. Epilepsia 2000, 41:818-824.
106. A receptor binding in young children with epilepsy. Epilepsia 2001, 42:1320-1326.
107. 11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 1998, 97:279-286.
108. Hammers A, Koepp MJ, Richardson MP, et al. Central benzodiazepine receptors in malformations of cortical development: a quantitative study. Brain 2001, 124:1555-1565.
109. Savic I, Pauli S, Thorell JO, Blomqvist G In vivo demonstration of altered benzodiazepine receptor density in patients with generalized epilepsy. J Neurol Neurosurg Psychiatr 1994, 57:797-804.
110. 11C]flumazenil and positron emission tomography. Epilepsia 1995, 36:113-121.
111. A receptor binding during absence seizures. Epilepsia 1995, 36:592-599.
112. 11C]flumazenil positron emission tomography study. Epilepsia 1997, 38:1089-1097.
113. 11C]methyl-l-tryptophan positron emission tomography. Ann Neurol 1998, 44:858-866.
114. 11C]methyl-l-tryptophan positron emission tomography scanning in 176 patients with intractable epilepsy. Ann Neurol 2002, 1(Suppl):S118.
115. Fedi M, Reutens D, Okazawa H, et al. Localizing value of alpha-methyl-l-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 2001, 57:1629-1636.
116. Juhász C, Chugani DC, Muzik O, et al. Alpha-methyl-l-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 2003, 60:960-968.
117. 11C] methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 2003, 60:756-761.
118. Simmons ML, Chavkin C Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 1996, 39:145-196.
119. Tortella FC, Long JB, Holaday JW Endogenous opioid systems: physiological role in the self-limitation of seizures. Brain Res 1985, 332:174-178.
120. Bartenstein PA, Duncan JS, Prevett MC, et al. Investigation of the opioid system in absence seizures with positro emission tomography. J Neurol Neurosurg Psychiatry 1993, 56:1295-1302.
121. Koepp MJ, Richardson MP, Brooks DJ, Duncan JS Focal cortical release of endogenous opioids during reading-induced seizures. Lancet 1998, 352:952-955.
122. Madar I, Lesser RP, Krauss G, et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 1997, 41:358-367.
123. 11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia 1995, 36:712-721.
124. 18F-FDG in focal epilepsy. Acta Neurol Scand 2001, 103:360-366.